Pharmacokinetic and toxicity investigations of a new intraocular lens with a dexamethasone drug delivery system: A pilot study

Ophthalmologica

Volumn 220, Issue 5, 2006, Pages 338-342

  Siqueira, Rubens C ^a,b,e   Ribeiro Filho, Elias ^c   Fialho, Sílvia L ^c   Lucena, Levy R ^a   Maia Filho, Alfredo ^a   Haddad, Antônio ^b   Jorge, Rodrigo ^b   Scott, Ingrid U ^d   Da Silva Cunha, Armando ^c  

^a University of Rio Preto   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

^e NONE   (Brazil)

Author keywords

Dexamethasone drug delivery systems; Intraocular lens, pharmacokinetics; Intraocular lens, toxicity

Indexed keywords

DEXAMETHASONE; POLY(METHYL METHACRYLATE);

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; ENUCLEATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; LENS IMPLANT; NONHUMAN; OPHTHALMOSCOPY; RABBIT; SLIT LAMP;

EID: 33748468776     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094626     Document Type: Article

References (16)

1. Apple DJ, Solomon KD, Tetz MR, et al: Posterior capsule opacification. Surv Ophthalmol 1992;37:73-116.
2. Sanders DR, Kraff M: Steroidal and nonsteroidal anti-inflammatory agents: effect on postsurgical inflammation and blood-aqueous humor barrier breakdown. Arch Ophthalmol 1984;102:1453-1456.
3. Järvinen K, Järvinen T, Urtti A: Ocular absorption following topical delivery. Adv Drug Del Rev 1995;16:3-19.
4. Ferguson VM, Spalton DJ: Recovery of the blood-aqueous barrier after cataract surgery. Br J Ophthalmol 1991;75:106-110.
5. Fialho SL, Silva-Cunha A: A new vehicle based on microemulsion for topical ocular administration of dexamethasone. Clin Exp Ophthalmol 2004;32:626-632.
6. Paganelli F, Cardillo JA, Melo LA Jr, et al: A single intraoperative sub-Tenon's capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation. Ophthalmology 2004;111:2102-2108.
7. Geroski DH, Edelhauser HF: Transscleral drug delivery for posterior segment disease. Adv Drug Del Rev 2001;52:37-48.
8. Fialho SL, Silva-Cunha A: Iontoforese no transporte ocular de drogas. Arq Bras Oftalmol 2004;67:839-845.
9. Tan DTH, Chee S, Lim L, et al: Randomized clinical trial of Surodex steroid drug delivery system for cataract surgery - Anterior versus posterior placement of two Surodex in the eye. Ophthalmology 2001;108:2172-2181.
10. Tan DTH, Chee S, Lim L, et al: Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of postcataract surgery inflammation. Ophthalmology 1999;106:223-231.
11. Fialho SL, Rego MGB, Cardillo JA, et al: Implantes biodegradáveis destinados à administração intra-ocular. Arq Bras Oftalmol 2003;66:891-896.
12. Fialho SL, Silva-Cunha A: Manufacturing techniques of biodegradable implants intended to intraocular application. Drug Del 2005;12:109-116.
13. Solomon KD, Cheetham JK, De Gryse R, et al: Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery. Ophthalmology 2001;108:331-337.
14. Kimura H, Ogura Y: Biodegradable polymers for ocular drug delivery. Ophthalmologies 2001;215:143-155.
15. Jain RA: The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000;21:2475-2490.
16. Wadood AC, Ambrecht AM, Aspinall PAD, et al: Safety and efficacy of a dexamethasone anterior segment drug delivery system in patients after phacoemulsification. J Cataract Refract Surg 2004;30:761-768.